Increased prevalence of infectious endocarditis in patients with type II diabetes mellitus

Mohammad Reza Movahed1, Mehrtash Hashemzadeh, M Mazen Jamal

  • 1Department of Medicine, Section of Cardiology, University of Arizona Sarver Heart Center, Tucson, AZ 85724, USA. rmova@aol.com

Abstract

Insights

Patients with diabetes mellitus (DM) face a higher risk of infectious endocarditis (IE). This study found DM independently associated with IE, even after accounting for other health conditions.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Endocrinology

Background:

  • Diabetes mellitus (DM) increases infection risk, but its link to infectious endocarditis (IE) is debated.
  • Previous reports on DM and IE association are controversial.
  • This study aimed to clarify the occurrence of IE in DM patients compared to a matched control group.

Purpose of the Study:

  • To evaluate the prevalence of infectious endocarditis (IE) in patients with diabetes mellitus (DM).
  • To compare IE occurrence in DM patients versus a control group without DM.
  • To determine if DM is an independent risk factor for IE.

Main Methods:

  • Retrospective analysis of inpatient discharge diagnosis codes (ICD-9) from Veterans Health Administration hospitals.
  • Comparison between a large cohort of DM patients (n=293,124) and a control group with hypertension but no DM (n=552,623).
  • Multivariate analysis adjusted for renal failure and valvular disease; statistical tests included unpaired t tests, chi-square, and Fisher's Exact Tests.

Main Results:

  • Infectious endocarditis (IE) was more prevalent in diabetes mellitus (DM) patients (0.5%) compared to controls (0.3%), a 40% relative increase.
  • Multivariate analysis confirmed DM as an independent risk factor for IE (OR=1.9; 95% CI=1.8-2.1; P<.0001).
  • The association remained significant after adjusting for renal failure and valvular abnormalities.

Conclusions:

  • Type II diabetes mellitus is associated with a significantly higher prevalence of infectious endocarditis.
  • This increased risk of IE in DM patients is independent of renal failure or valvular abnormalities.
  • Findings suggest enhanced vulnerability of diabetic patients to infections like IE.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...